» Articles » PMID: 37260698

High-sensitivity HBV DNA Test for the Diagnosis of Occult HBV Infection: Commonly Used but Not Reliable

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Occult hepatitis B virus (HBV) infection (OBI) is a condition in which replication-competent viral DNA is detected in the liver (with detectable or undetectable HBV DNA in serum) of individual testing negative for HBV surface antigen (HBsAg). It is a risk factor for transfusion or transplant transmission, reactivation after immunosuppression or chemotherapy, and progression of chronic liver disease and hepatocarcinogenesis. The long-term stable presence of covalently closed circular DNA (cccDNA), which is fully replicative in the nucleus of infected hepatocytes is the molecular basis for the formation of OBI. HBV genome in liver tissue, HBV DNA and anti-HBc test in serum are the gold standard, common method and alternative markers for OBI diagnosis, respectively. Due to the stability of covalently closed circular DNA (cccDNA) and the long half-life of hepatocytes, the existence of OBI is extensive and prolonged. The low and/or intermittent replication of HBV in OBI patients, the limitations of the sensitivity of serological tests, and the non-standardized and invasive nature of liver histology render the "commonly used" serological tests are unreliable and the "gold standard" liver histology is impractical, thus the findings from studies on the formation, diagnosis and transplantation or transfusion transmission of HBV in OBI strongly suggest that the "alternative" marker, the anti-HBc test, may be the most reliable and practical approach for OBI diagnosis.

Citing Articles

Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region.

Alshrari A, Hudu S, Shinkafi S, Tahir A, Raji H, Jimoh A Diagnostics (Basel). 2025; 15(4).

PMID: 40002636 PMC: 11854421. DOI: 10.3390/diagnostics15040486.


A critical review of diagnostic and prognostic markers of chronic hepatitis B infection.

Hudu S, Shinkafi S, Jimoh A Med Rev (2021). 2024; 4(3):225-234.

PMID: 38919396 PMC: 11195425. DOI: 10.1515/mr-2024-0022.


Frequency of HBsAg variants in occult hepatitis B virus infected patients and detection by ARCHITECT HBsAg quantitative.

He C, Liu Y, Jiang X, Xu Z, Xiang Z, Lu Z Front Cell Infect Microbiol. 2024; 14:1368473.

PMID: 38766475 PMC: 11099262. DOI: 10.3389/fcimb.2024.1368473.


Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy.

Damiani A, Holzmayer V, Galli C, De Nuzzo M, Anderson M, Cloherty G Viruses. 2024; 16(1).

PMID: 38257771 PMC: 10819115. DOI: 10.3390/v16010071.

References
1.
Boyd A, Lacombe K, Lavocat F, Maylin S, Miailhes P, Lascoux-Combe C . Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. J Hepatol. 2016; 65(4):683-691. DOI: 10.1016/j.jhep.2016.05.014. View

2.
Cai J, Wu W, Wu J, Chen Z, Wu Z, Tang Y . Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA. Ann Transl Med. 2022; 10(1):25. PMC: 8825549. DOI: 10.21037/atm-21-6272. View

3.
Zeuzem S, de Man R, Honkoop P, Roth W, Schalm S, Schmidt J . Dynamics of hepatitis B virus infection in vivo. J Hepatol. 1997; 27(3):431-6. DOI: 10.1016/s0168-8278(97)80345-5. View

4.
Bes M, Vargas V, Piron M, Casamitjana N, Esteban J, Vilanova N . T cell responses and viral variability in blood donation candidates with occult hepatitis B infection. J Hepatol. 2011; 56(4):765-74. DOI: 10.1016/j.jhep.2011.11.011. View

5.
Prieto M, Gomez M, Berenguer M, Cordoba J, Rayon J, Pastor M . De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl. 2001; 7(1):51-8. DOI: 10.1053/jlts.2001.20786. View